Intranasal immunization with synthetic recombinant vaccine containing multiple epitopes of influenza virus.
about
Development of universal influenza vaccines based on influenza virus M and NP genes.Advances in novel influenza vaccines: a patent review.Immunization with a hemagglutinin-derived synthetic peptide formulated with a CpG-DNA-liposome complex induced protection against lethal influenza virus infection in mice.Influenza A virus nucleoprotein derived from Escherichia coli or recombinant vaccinia (Tiantan) virus elicits robust cross-protection in micePhage displaying peptides mimic schistosoma antigenic epitopes selected by rat natural antibodies and protective immunity induced by their immunization in mice.Chimeric flagellin expressed by Salmonella typhimurium induces an ESAT-6-specific Th1-type immune response and CTL effects following intranasal immunizationOptimization of electroporation-enhanced intradermal delivery of DNA vaccine using a minimally invasive surface device.Enhanced humoural and cellular immune responses to influenza H7N9 antigen HA1-2 fused with flagellin in chickens.A recombinant flagellin-poxvirus fusion protein vaccine elicits complement-dependent protection against respiratory challenge with vaccinia virus in miceFlagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis.Evaluation of influenza-specific humoral response by microbead array analysisProtection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin.Rapid high-yield expression of a candidate influenza vaccine based on the ectodomain of M2 protein linked to flagellin in plants using viral vectors.Protective Efficacy of the Conserved NP, PB1, and M1 Proteins as Immunogens in DNA- and Vaccinia Virus-Based Universal Influenza A Virus Vaccines in Mice.Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral ChallengeFlagellin-F1-V fusion protein is an effective plague vaccine in mice and two species of nonhuman primates.Enhanced antigen processing of flagellin fusion proteins promotes the antigen-specific CD8+ T cell response independently of TLR5 and MyD88.Flagellin as an adjuvant: cellular mechanisms and potential.Mucosal administration of flagellin induces innate immunity in the mouse lung.Human influenza vaccines and assessment of immunogenicity.Flagellin a toll-like receptor 5 agonist as an adjuvant in chicken vaccines.DNA-epitope vaccine provided efficient protection to mice against lethal dose of influenza A virus H1N1.DNA-vaccine platform development against H1N1 subtype of swine influenza A viruses.Study of immunogenicity of recombinant proteins based on hemagglutinin and neuraminidase conservative epitopes of influenza A virusIRES-based co-expression of influenza virus conserved genes can promote synergistic antiviral effects both in vitro and in vivo.Escherichia coli flagellin stimulates pro-inflammatory immune response.Heterosubtypic influenza protection elicited by double-layered polypeptide nanoparticles in miceBaculovirus Surface Display of Immunogenic Proteins for Vaccine DevelopmentAlternative routes of influenza vaccine delivery
P2860
Q30355116-13BC0E97-7B88-4354-AC42-EBA2F2FE9885Q30388514-E917D441-E4BF-471D-8A9A-F42D572B87D7Q30423481-93F38377-F354-4E76-8B97-76591CA25EACQ30425194-2A35BB5A-F807-4865-ADC5-4C4083154321Q33215338-9A5E8A09-2313-49A5-8785-80574302704FQ33577674-1C93990C-637D-4DF5-898A-D8200BF3B798Q33586294-4CE8D684-73FC-4EE0-96AA-4C5BB1AB2F75Q33823583-BB49681A-E7AE-4B7B-AC1C-CE7A9103416BQ33905188-E6FD9123-18BC-4698-9F6A-F2FC8191BF05Q34334406-572D3F2F-43A6-4B65-AA35-1ECA2DA74F07Q34789793-FA344508-7420-41AF-9B45-17C7E32821BDQ35209148-5F2B3460-CE19-462A-91A9-7CA118FEF29AQ35645628-E2D6F0D5-D64B-446F-9E03-F8A207C3707EQ35656657-851E74B9-E527-4A2B-B567-E028D0190337Q36104042-8B1385F0-7FF0-47DB-862A-9ABB285BA8C2Q37051021-FD8C3F96-A05B-4C60-BF14-EB109C4835FCQ37095534-61063ACD-29EF-4E62-B4CB-78687EEE2B40Q37130379-BAB9AA0D-0FF6-4A1E-B1A1-6C1922036F24Q37582895-32E9B1C7-8B57-47F6-BBA1-F018CC9BAA0BQ37812125-E296EF08-F315-4430-9800-2B56355AE0D7Q38180851-B9566D2B-BA75-44C4-ABE2-662F7548F978Q39036094-359C6F3C-8324-486E-B40E-9C91C631DB0BQ39311178-2E41D3E6-2E7A-41B1-9969-5C93F919BAEFQ42113474-BF2BFDBB-C0D4-46EC-841B-4D9D685F1840Q47262061-9D6CEB5C-6547-401C-AC76-7B6048AA4D1FQ54332206-363211BA-4E97-4721-B5A9-46C18FABAB63Q56221441-63B2CF10-99A5-48A1-B426-79611DB622BCQ56514706-CE18063D-1602-4AF3-A4D6-C963BA4DD321Q57114644-A6674956-460D-4430-A952-39C8312C2C91
P2860
Intranasal immunization with synthetic recombinant vaccine containing multiple epitopes of influenza virus.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Intranasal immunization with s ...... e epitopes of influenza virus.
@en
Intranasal immunization with s ...... e epitopes of influenza virus.
@nl
type
label
Intranasal immunization with s ...... e epitopes of influenza virus.
@en
Intranasal immunization with s ...... e epitopes of influenza virus.
@nl
prefLabel
Intranasal immunization with s ...... e epitopes of influenza virus.
@en
Intranasal immunization with s ...... e epitopes of influenza virus.
@nl
P1433
P1476
Intranasal immunization with s ...... e epitopes of influenza virus.
@en
P2093
Sung Ho Jeon
Tamar Ben-Yedidia
P304
P356
10.1016/S0264-410X(02)00187-1
P407
P50
P577
2002-06-01T00:00:00Z